Get startedLog in
    Picture of Galderma AG logo

    GALD — Galderma AG News Story

    0.000.00%
    ch flag iconLast trade - 00:00
    Consumer DefensivesAdventurousLarge CapHigh Flyer
    All News

    Brief: Galderma Says Nemluvio Shows Long-Term Control In Prurigo Nodularis Up To 3 Years

    Picture of Galderma AG logoGalderma AG
    27/02/2026 06:02
    Feb 27 (Reuters) - Galderma Group Ltd GALD.S:

GALDERMA GROUP LTD - NEMLUVIO SHOWS LONG-TERM CONTROL IN PRURIGO NODULARIS UP TO 3 YEARS

GALDERMA GROUP LTD - THESE RESULTS, TO BE PRESENTED AT 2026 WINTER CLINICAL™ MIAMI, MARK LONGEST LTE STUDY IN PRURIGO NODULARIS REPORTED TO DATE

Source text: ID:nBw69mjM9a

Further company coverage: GALD.S

 (Gdansk Newsroom)

 ((gdansk.newsroom@thomsonreuters.com; +48 58 7696600;))

    Recent news on Galderma AG

    See all news